DIAZOXIDE

作品数:19被引量:33H指数:4
导出分析报告
相关领域:医药卫生更多>>
相关作者:宋治远仝识非钟理胡红玲赵建平更多>>
相关机构:第三军医大学西南医院华中科技大学第三军医大学附属西南医院重庆医科大学更多>>
相关期刊:《介入放射学杂志》《Chinese Medical Journal》《外科研究与新技术(中英文)》《中国心脏起搏与心电生理杂志》更多>>
相关基金:国家自然科学基金国家教育部博士点基金国家科技支撑计划更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Pediatric Investigationx
条 记 录,以下是1-1
视图:
排序:
Efficacy and safety of octreotide treatment for diazoxide-unresponsive congenital hyperinsulinism in China被引量:1
《Pediatric Investigation》2020年第1期29-36,共8页Bingyan Cao Di Wu Chang Su Jiajia Chen Xuejun Liang Min Liu Wenjing Li Xiaoqiao Li Chunxiu Gong 
The study was funded by National Key Research and Development Program of China(2016YFC1305304);Beijing Children's Hospital Young Investigator Program(No.BCHYIPA-2016-06);Beijing Municipal Administration of Hospital Clinical Medicine Development of Special Funding Support(No.ZYLX201821).
Importance: Octreotide is an off-label medicine for congenital hyperinsulinism (CHI), but is currently widely used for treatment of patients with CHI. Thus far, variable efficacy and adverse effects have been reported...
关键词:OCTREOTIDE Congenital hyperinsulinism EFFICACY Safety 
检索报告 对象比较 聚类工具 使用帮助 返回顶部